You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR REPATHA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for REPATHA

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01375764 ↗	Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects	Completed	Amgen	Phase 2	2011-07-28	The primary objective was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145), compared with ezetimibe, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia unable to tolerate an effective dose of a statin.
NCT01375777 ↗	Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels	Completed	Amgen	Phase 2	2011-07-06	The primary objective was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145) every 2 weeks (Q2W) or every 4 weeks (Q4W), compared with placebo, on the percent change from baseline in LDL-C when used as monotherapy in adults with hypercholesterolemia.
NCT01516879 ↗	Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study	Completed	Amgen	Phase 3	2012-01-05	To evaluate the efficacy, safety, and tolerability of 52 weeks of subcutaneous (SC) evolocumab (AMG 145) compared with placebo when added to assigned background lipid-lowering therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for REPATHA

Condition Name

Chart
Table

Condition Name for REPATHA
Intervention	Trials
Hyperlipidemia	7
Coronary Artery Disease	5
Hypercholesterolemia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for REPATHA
Intervention	Trials
Hyperlipidemias	15
Hypercholesterolemia	12
Dyslipidemias	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for REPATHA

Trials by Country

Map
Table

Trials by Country for REPATHA
Location	Trials
United States	357
Japan	92
Canada	78
Australia	53
Spain	49
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for REPATHA
Location	Trials
New York	20
Ohio	17
California	17
Florida	14
North Carolina	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for REPATHA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for REPATHA
Clinical Trial Phase	Trials
Phase 4	23
Phase 3	18
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for REPATHA
Clinical Trial Phase	Trials
Completed	23
Recruiting	21
Not yet recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for REPATHA

Sponsor Name

Chart
Table

Sponsor Name for REPATHA
Sponsor	Trials
Amgen	34
NYU Langone Health	3
University of California, Los Angeles	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for REPATHA
Sponsor	Trials
Other	54
Industry	40
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.